Dialysis tubing implant assay in the rat: A novel in vivo method for identifying inhibitors of matrix metalloproteinases

Drug Development Research

Volumn 43, Issue 4, 1998, Pages 200-205

  DiJoseph, John F ^a   Sharr, Michele A ^a  

^a PFIZER INC   (United States)

Author keywords

Bioactivity; Collagenase; Pharmacodynamic; Stromelysin

Indexed keywords

COLLAGENASE; ENZYME INHIBITOR; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; DRUG ACTIVITY; DRUG TARGETING; ENZYME ACTIVITY; FLUORESCENCE; IMPLANT; INTRAVENOUS DRUG ADMINISTRATION; MODEL; MOLECULAR WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PLEURA CAVITY; RAT; RHEUMATOID ARTHRITIS;

EID: 0031847139     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199804)43:4<200::AID-DDR3>3.0.CO;2-M     Document Type: Article

References (14)

1. Brinkerhoff CE (1991): Joint destruction in arthritis: Metalloproteinases in the spotlight. Arthritis Rheum 34:1073-1075.
2. Broadhurst MJ, Brown PA, Johnson WH, Lawton G (1993): European Patent Application Number 0 575 844 A2.
3. Case JP Sano H, Lafyatis R, Renimers EF, Kumkumian GK, Wilder RL (1989): Stromelysin expression in the synovium of rats with experimental erosive arthritis. J Clin Inv 84:1731-1740.
4. Cawston TE (1996): Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 70:1613-182.
5. Chander SK, Antoniw P, Beeley NRA, Boyce B, Crabbe T, Docherty AJP, Leonard J, Mason B, Millar K, Millican AT, Morphy R, Mountain A, O'Connell J, Porter JR, Willmott N (1995): An in vivo model for screening peptidomimetic inhibitors of gelatinase A. J Pharm Sci 84:404-409.
6. Chapman KT, Kopka IE, Durette PL, Esser CK, Lanza TH, Izquierdo-Martin M, Niedzwiecki L, Chang B, Harrison RK, Kuo DW, Lin T-Y, Stein RL, Hagmann WK (1993): Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides. J Med Chem 36: 4293-4301.
7. Chapman KT, Durette PL, Caldwell CG, Sperow KM, Niedzwieeki LM, Harrison RK, Saphos C, Christen AJ, Olszewski JM, Moore VL, MacCoss M, Hagmann WK (1996): Orally active inhibitors of stromelysin-1 (MMP-3). Bioorg Med Chem Lett 6:803-806.
8. Knight GC, Willenbrock F, Murphy G (1992): A novel coumarin-labelled peptide for sensitive continous assays of the matrix metalloproteinases. FEBS 296:263-266.
9. Lark MW, Saphos CA, Walakovits LA, Moore VL (1990): In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP). Biochem Pharm 39:2041-2049.
10. MacNaul KL, Chartrain N, Lark M, Tocei J, Hutchinson NI (1990): Discoordinate expression of stromelysin, collagenase and TIMP in human rheumatoid synovial fibroblasts: Synergistic effects of IL-1 and TNF on stromelysin expression. J Biol Chem 265; 17238-17245.
11. MacPherson LJ, Bayburt EK, Capparelli MP, Carroll BJ, Goldstein R, Justice MR, Zhn L, Hu S-I, Melton RA, Fryer L, Goldberg RL, Doughty JR, Spirito S, Blancuzzi V, Wilson D, O'Byrne EM, Ganu V, Parker DT (1997): Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem 40:2525-2532.
12. O'Byrne EM, Parker DT, Roberts ED, Goldberg RL, MacPherson LJ, Blancuzzi V, Wilson D, Singh HN, Ludewig R, Ganu VS (1995): Oral administration of a matrix metalloproteinase inhibitor. CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits. Inflamm Res 44(Suppl 2):S117-S118.
13. Weingarten H, Feder J (1985): Spectrophotometric assay for vertebrate collagenase. Anal Biochem 147:437-440.
14. Zask A, Levin JI, Killar LM, Skotnicki JS (1996): Inhibition of matrix metalloproteinases: Structure based design. Curr Pharm Des 2:624-661.